| Literature DB >> 32110715 |
Bert A 't Hart1,2.
Abstract
Aging Western societies are facing an increasing prevalence of chronic autoimmune-mediated inflammatory disorders (<span class="Chemical">AIMIDs) for which treatments that are safe and effective are scarce. One of the main reasons for this situation is the lack of animal models, which accu<span class="Species">rately replicate clinical and pathological aspects of the human diseases. One important AIMID is the neuroinflammatory disease multiple sclerosis (MS), for which the mouse experimental autoimmune encephalomyelitis (EAE) model has been frequently used in preclinical research. Despite some successes, there is a long list of experimental treatments that have failed to reproduce promising effects observed in murine EAE models when they were tested in the clinic. This frustrating situation indicates a wide validity gap between mouse EAE and MS. This monography describes the development of an EAE model in nonhuman primates, which may help to bridge the gap. Copyright:Entities:
Year: 2019 PMID: 32110715 PMCID: PMC7041540 DOI: 10.5194/pb-6-17-2019
Source DB: PubMed Journal: Primate Biol ISSN: 2363-4715